5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.12%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
202.67%
Positive gross profit growth while HUH1V.HE is negative. John Neff would see a clear operational edge over the competitor.
269.03%
EBIT growth above 1.5x HUH1V.HE's 13.06%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
269.03%
Operating income growth above 1.5x HUH1V.HE's 13.06%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
418.89%
Positive net income growth while HUH1V.HE is negative. John Neff might see a big relative performance advantage.
414.96%
Positive EPS growth while HUH1V.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
414.96%
Positive diluted EPS growth while HUH1V.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
1.11%
Slight or no buybacks while HUH1V.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.11%
Slight or no buyback while HUH1V.HE is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
153.49%
OCF growth above 1.5x HUH1V.HE's 41.69%. David Dodd would confirm a clear edge in underlying cash generation.
-74.15%
Negative FCF growth while HUH1V.HE is at 96.54%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-3.36%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 67.23%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
1.08%
5Y revenue/share CAGR under 50% of HUH1V.HE's 20.60%. Michael Burry would suspect a significant competitive gap or product weakness.
-4.19%
Negative 3Y CAGR while HUH1V.HE stands at 15.04%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-91.08%
Negative 10Y OCF/share CAGR while HUH1V.HE stands at 154.37%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-89.59%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-92.29%
Negative 3Y OCF/share CAGR while HUH1V.HE stands at 126.37%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
37.31%
Below 50% of HUH1V.HE's 95.24%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-12.49%
Negative 5Y net income/share CAGR while HUH1V.HE is 37.36%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-64.04%
Negative 3Y CAGR while HUH1V.HE is 40.29%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
108.37%
10Y equity/share CAGR in line with HUH1V.HE's 117.87%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
36.57%
5Y equity/share CAGR at 75-90% of HUH1V.HE's 41.67%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
7.77%
Below 50% of HUH1V.HE's 34.88%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.40%
Inventory growth well above HUH1V.HE's 2.03%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.00%
Asset growth above 1.5x HUH1V.HE's 1.19%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
1.73%
Positive BV/share change while HUH1V.HE is negative. John Neff sees a clear edge over a competitor losing equity.
-80.84%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.